Kristian Aabo

1.5k total citations
38 papers, 694 citations indexed

About

Kristian Aabo is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Kristian Aabo has authored 38 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Epidemiology. Recurrent topics in Kristian Aabo's work include Lung Cancer Research Studies (8 papers), Neuroendocrine Tumor Research Advances (6 papers) and Cancer Treatment and Pharmacology (5 papers). Kristian Aabo is often cited by papers focused on Lung Cancer Research Studies (8 papers), Neuroendocrine Tumor Research Advances (6 papers) and Cancer Treatment and Pharmacology (5 papers). Kristian Aabo collaborates with scholars based in Denmark, United States and United Kingdom. Kristian Aabo's co-authors include P Dombernowsky, S Walbom-Jørgensen, Renzo Canetta, P I Adnitt, Howard W. Bruckner, Harvey Brodovsky, Nicoletta Colombo, Malcolm Adams, David S. Alberts and V. Barley and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Kristian Aabo

37 papers receiving 648 citations

Peers

Kristian Aabo
Comparison fields: 5 of 78
  • Oncology 282
  • Surgery 183
  • Reproductive Medicine 177
  • Pulmonary and Respiratory Medicine 152
  • Pathology and Forensic Medicine 129
Replace J Chauvergne with:
J Chauvergne France
B Kabakow United States
M. Berman United States
P. Harper United Kingdom
DeVita Vt United States
C. P. J. Vendrik Netherlands
Martine George United States
V.J. Harvey New Zealand
G. Salerno Italy
E Silverberg United States
J Chauvergne France View profile →
Citations per field, relative to Kristian Aabo
Kristian Aabo · 1×
Citations per year, relative to Kristian Aabo
Kristian Aabo · 1×

Countries citing papers authored by Kristian Aabo

Since Specialization
Citations

This map shows the geographic impact of Kristian Aabo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristian Aabo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristian Aabo more than expected).

Fields of papers citing papers by Kristian Aabo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristian Aabo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristian Aabo. The network helps show where Kristian Aabo may publish in the future.

Co-authorship network of co-authors of Kristian Aabo

This figure shows the co-authorship network connecting the top 25 collaborators of Kristian Aabo. A scholar is included among the top collaborators of Kristian Aabo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristian Aabo. Kristian Aabo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 68
2 5
3 2
4 4
5 45
6 18
7 4
8 6
9 8
10 2
11 9
12
Cisplatin in the treatment of advanced gastric carcinoma: a phase II study.
20
13 23
14
Surgical management of intestinal obstruction in the late course of malignant disease.
24
15
[Acute cardiac failure precipitated by anesthesia and surgery in patients treated with adriamycin].
1
16
Phase II study of procarbazine in small cell carcinoma of the lung.
11
17
High-dose medroxyprogesterone acetate (MPA) in advanced chemotherapy-resistant ovarian carcinoma: a phase II study.
17
18 6
19 4
20 24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026